In order to inhibit Bcl-XL expression or function, antisense oligonucleotides [6] or short peptides (that bind to Bcl-XL and Bcl-2 [7]) have been developed and shown to promote apoptosis signaling and cell death in HNSCC cell lines. This evidence concerns the gene BCL2 and head and neck squamous cell carcinoma.